1. Home
  2. AVXL vs RSKD Comparison

AVXL vs RSKD Comparison

Compare AVXL & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • RSKD
  • Stock Information
  • Founded
  • AVXL 2004
  • RSKD 2012
  • Country
  • AVXL United States
  • RSKD United States
  • Employees
  • AVXL N/A
  • RSKD N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • RSKD EDP Services
  • Sector
  • AVXL Health Care
  • RSKD Technology
  • Exchange
  • AVXL Nasdaq
  • RSKD Nasdaq
  • Market Cap
  • AVXL 635.6M
  • RSKD 743.4M
  • IPO Year
  • AVXL N/A
  • RSKD 2021
  • Fundamental
  • Price
  • AVXL $3.71
  • RSKD $4.50
  • Analyst Decision
  • AVXL Strong Buy
  • RSKD Buy
  • Analyst Count
  • AVXL 3
  • RSKD 8
  • Target Price
  • AVXL $33.00
  • RSKD $5.91
  • AVG Volume (30 Days)
  • AVXL 2.9M
  • RSKD 617.8K
  • Earning Date
  • AVXL 12-22-2025
  • RSKD 11-12-2025
  • Dividend Yield
  • AVXL N/A
  • RSKD N/A
  • EPS Growth
  • AVXL N/A
  • RSKD N/A
  • EPS
  • AVXL N/A
  • RSKD N/A
  • Revenue
  • AVXL N/A
  • RSKD $338,838,000.00
  • Revenue This Year
  • AVXL N/A
  • RSKD $6.28
  • Revenue Next Year
  • AVXL N/A
  • RSKD $9.78
  • P/E Ratio
  • AVXL N/A
  • RSKD N/A
  • Revenue Growth
  • AVXL N/A
  • RSKD 6.54
  • 52 Week Low
  • AVXL $2.86
  • RSKD $3.94
  • 52 Week High
  • AVXL $14.44
  • RSKD $6.00
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 14.26
  • RSKD 38.97
  • Support Level
  • AVXL $6.35
  • RSKD $4.80
  • Resistance Level
  • AVXL $7.25
  • RSKD $5.21
  • Average True Range (ATR)
  • AVXL 0.64
  • RSKD 0.17
  • MACD
  • AVXL -0.34
  • RSKD -0.00
  • Stochastic Oscillator
  • AVXL 14.49
  • RSKD 0.68

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

Share on Social Networks: